Metabolic origins and clinical significance of LDL heterogeneity.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic concepts and observational literature without systematic review methodology.
PubMed 12235168 · doi:10.1194/jlr.r200004-jlr200
What was done
This narrative review summarizes metabolic turnover studies and observational evidence regarding the origins of low-density lipoprotein (LDL) heterogeneity and the pathophysiological relevance of distinct LDL subspecies.
What was found
The abstract reports no numerical data. It describes that LDL heterogeneity arises from multiple pathways, including the catabolism of VLDL and IDL precursors, metabolic remodeling, and direct production. A profile termed the atherogenic lipoprotein phenotype is marked by small dense LDL, elevated triglyceride-rich remnants and IDLs, reduced HDL, and insulin resistance, conferring increased coronary heart disease risk. Mechanisms supporting the atherogenicity of small dense LDL include increased subendothelial transport, binding to arterial proteoglycans, and susceptibility to oxidation. Large LDL particles are also noted to exhibit reduced LDL receptor affinity relative to intermediate-sized LDL and associate with coronary disease in specific lipid contexts.
Why it matters
Understanding the distinct metabolic pathways and pathological characteristics of LDL subspecies helps explain residual cardiovascular risk not captured by standard lipid panels, particularly in individuals with insulin resistance.
Limits
The abstract provides a qualitative summary without presenting quantitative effect sizes, statistical metrics, sample sizes, or a systematic search strategy.
Cited by
- supports Smaller, dense LDL particles have a greater tendency to enter the arterial wall, bind more tightly to artery tissue, and oxidize more rapidly compared to large LDL particles.